Eriksen B O, Ingebretsen O C
Department of Nephrology and Clinical Research Centre, University Hospital of North Norway, Tromsø, Norway.
Kidney Int. 2006 Jan;69(2):375-82. doi: 10.1038/sj.ki.5000058.
The increase in demand for renal replacement therapy makes it important to investigate the prognosis of the earlier stages of chronic kidney disease (CKD). We examined the change in glomerular filtration rate (GFR), and patient and renal survival in CKD stage 3 in the municipality of Tromsø, a well-defined European community with a population of 58,000. All patients with estimated GFR between 30 and 59 ml/min/1.73 m(2) for more than 3 months during a 10-year study period were identified from a complete database of all 248 560 measurements of serum creatinine made in the community in the study period. Change in GFR was estimated for each patient using a multilevel model. A complete follow-up with respect to patient and renal survival was obtained from hospital databases. A total of 3047 patients was included. The median number of measurements of creatinine for each patient was 9, and the median observation time was 44 months. Mean estimated change in GFR was--1.03 ml/min/1.73 m(2)/year. Seventy-three percent of the patients experienced a decline in GFR. The 10-year cumulative incidence of renal failure was 0.04 (95% CI 0.03-0.06) and mortality 0.51 (95% CI 0.48-0.55). Female gender was associated with slower decline in GFR and better patient and renal survival. In this population-based study, the decline in GFR in CKD was slower than in previously studied selected patient groups. A high mortality pre-empted the development of renal failure in many patients. The prognosis of CKD depended strongly on gender.
肾脏替代疗法需求的增加使得研究慢性肾脏病(CKD)早期阶段的预后变得很重要。我们在特罗姆瑟市(一个拥有58000人口、界定明确的欧洲社区)研究了CKD 3期患者的肾小球滤过率(GFR)变化、患者生存率和肾脏生存率。在一项为期10年的研究期间,从该社区所有248560次血清肌酐测量的完整数据库中,识别出所有估计GFR在30至59 ml/min/1.73 m²且持续超过3个月的患者。使用多水平模型估计每位患者的GFR变化。从医院数据库获得了关于患者生存率和肾脏生存率的完整随访数据。共纳入3047例患者。每位患者肌酐测量的中位数为9次,中位观察时间为44个月。GFR的平均估计变化为-1.03 ml/min/1.73 m²/年。73%的患者GFR下降。肾衰竭的10年累积发病率为0.04(95%CI 0.03 - 0.06),死亡率为0.51(95%CI 0.48 - 0.55)。女性与GFR下降较慢以及更好的患者生存率和肾脏生存率相关。在这项基于人群的研究中,CKD患者的GFR下降比之前研究的特定患者群体要慢。高死亡率在许多患者中先于肾衰竭的发生。CKD的预后在很大程度上取决于性别。